Rutgers University was selected as one of five new hubs under the National Institutes of Health’s Research Evaluation and Commercialization Hubs (REACH) program, to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics and tools to improve patient care, enhance health and train the next generation of innovators. The new Rutgers Optimizes Innovation (ROI) Program, supported by $4 million over four years, will integrate the university’s strengths in the biomedical/bioengineering sciences and the expertise of its Research Commercialization team within the Office of Research and Economic Development to uncover, develop and guide innovators through the commercialization process with financial, regulatory and IP protection; mentoring management and educational resources. Please read more here.